Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01EHI
|
|||
| Former ID |
DIB011555
|
|||
| Drug Name |
Live attenuated H1N1 pandemic influenza vaccine
|
|||
| Synonyms |
Live attenuated H1N1 pandemic influenza vaccine (nasal); MEDI-3414; Live attenuated H1N1 pandemic influenza vaccine (nasal), MedImmune; LAIV (H1N1, nasal), MedImmune
Click to Show/Hide
|
|||
| Indication | Influenza virus infection [ICD-11: 1E30-1E32] | Approved | [1], [2] | |
| Company |
Medlmmune LLC
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT00945893) A Study to Evaluate the Safety of H1N1 Monovalent Vaccine (MEDI3414) in Healthy Adults. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.